CLEARONE INC
ClearOne is a public company that previously designed, developed, and marketed professional audio conferencing, microphone, and video collaboration solutions. Following the October 24, 2025 sale of certain intellectual property, product inventory, and non-exclusive customer-data rights to Biamp Systems, LLC, ClearOne no longer manufactures or sells products. It retains a limited inventory to service warranty claims and provides customer support for legacy products under its published policies. ClearOne’s continuing activities include fulfilling warranty and technical support obligations, managing and liquidating remaining assets of its legacy operating business, collecting accounts receivable, recovering prepaid assets, satisfying liabilities, and maintaining public-company compliance. It also evaluates potential strategic transactions. Its headquarters are in West Jordan, Utah.
No enriched coverage for $CLRO in the last 7 days.
No SEC Form 4 filings for $CLRO in the last 30 days.
See all $CLRO insider activity →ClearOne (CLRO) secured a $200,000 non-interest-bearing loan from First Finance for working capital. The loan is repayable at an agreed time, with no prepayment penalties, and is governed by Nevada law, per an SEC filing.
CLEARONE INC (CLRO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On October 14, 2026, ClearOne, Inc. (the "Company") entered into a Loan Agreement (the "Loan Agreement") with First Finance Ltd. ("First Finance"), effective as of October 7, 2026, pursuant to which First Finance agreed to len
Nasdaq notified ClearOne (CLRO) of a potential delisting due to insufficient stockholders' equity. The company plans to request a hearing by October 15, 2026, to contest the decision. Trading may be suspended if no hearing is requested.
Recent CLRO coverage spans corporate actions, financial news and mergers & acquisitions.
The small, non‑interest loan is unlikely to move the stock materially.
The loan is small, non‑interest bearing and unsecured, providing limited liquidity for working capital.
The delisting risk creates downward pressure on CLRO shares as investors may sell to avoid suspension.
Potential dilution and new capital raise may pressure the share price in the short term.
The 8-K confirms a new advisor engagement, but the excerpt provides no deal economics or performance milestones, limiting near-term earnings or cash-flow implications.
AlphAI scores every news story that mentions CLRO with an AI model for sentiment and relevance, and aggregates insider trades from CLEARONE INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
ClearOne (CLRO) secured a $200,000 non-interest-bearing loan from First Finance for working capital. The loan is repayable at an agreed time, with no prepayment penalties, and is governed by Nevada law, per an SEC filing.
CLEARONE INC (CLRO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On October 14, 2026, ClearOne, Inc. (the "Company") entered into a Loan Agreement (the "Loan Agreement") with First Finance Ltd. ("First Finance"), effective as of October 7, 2026, pursuant to which First Finance agreed to len
Nasdaq notified ClearOne (CLRO) of a potential delisting due to insufficient stockholders' equity. The company plans to request a hearing by October 15, 2026, to contest the decision. Trading may be suspended if no hearing is requested.
CLEARONE INC (CLRO) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On August 25, 2026, a stockholder (the “Consenting Stockholder”) of ClearOne, Inc. (the “Company”), holding at least a majority of the voting power of the Company’s outstanding shares of capital stock entitled to vote
CLEARONE INC (CLRO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On August 7, 2026, ClearOne, Inc. (the “Company”) entered into advisor agreements (the “Advisor Agreements”) with each of First Finance Ltd., Betelgeuse Capital Advisors Inc., Gang3 Capital Ltd. and JJK Holdings Ltd. (the “Adv
ClearOne (CLRO) shares jumped about 98% after hours after a majority stockholder, First Finance Ltd., approved by written consent the issuance of 12.5 million common shares tied to a merger, exceeding 20% of outstanding shares and triggering a change-of-control. The issuance takes effect 20 days after shareholder disclosure. ClearOne canceled First Finance warrants and signed CFO Simon Brewer to a new deal with $300,000 salary and 200,000 options.
CLEARONE INC (CLRO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On August 4, 2026, ClearOne, Inc. (the “Company”) entered into a warrant cancellation agreement (the “Warrant Cancellation Agreement”) with First Finance Ltd., whereby the Company and First Finance Ltd. agreed that warrants to
U.S. indices fell Tuesday. The article highlights five stocks: SpaceX (SPCX) fell 6.83% to $149.47; ClearOne (CLRO) jumped 97.71% to $13.84 after a definitive merger with Cortigent and related financing; FuelCell Energy (FCEL) fell 12.68% to $25.96; Cloudflare (NET) rose 8.60% to $268.83; Penguin Solutions (PENG) fell 7.38% to $62.71 after raising FY26 outlook (revenue +22%±2%, adj. EPS $2.60±$0.05).
CLEARONE INC (CLRO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 7 ex21_1.htm EXHIBIT 2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER BY AND AMONG CLEARONE INC., CLRO MERGER SUB, INC., CORTIGENT, INC. AND VIVANI MEDICAL, INC. Dated as of July 1, 2026 Page ARTICLE 1 DESCRIPTION OF TRANSACTION 2 1.1 Structure of the Merger 2 1.2 Effects of t
ClearOne, Inc. (CLRO) shares rose 30.41% to $4.19 on Thursday after the company said it signed a definitive merger agreement under which Vivani Medical’s subsidiary Cortigent will become a wholly owned ClearOne unit. ClearOne plans a $10m–$15m concurrent financing. Cortigent develops implantable neurostimulation technologies.
